# Combination of CXD and Restrictive Ketogenic Diet Against MASLD

> **NCT07639866** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Shanghai Municipal Hospital of Traditional Chinese Medicine** · enrollment: 135 (estimated)

## Conditions studied

- MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)

## Interventions

- **DIETARY_SUPPLEMENT:** Low-carbon control group
- **DIETARY_SUPPLEMENT:** KD group
- **DRUG:** CXD and KD group

## Key facts

- **NCT ID:** NCT07639866
- **Lead sponsor:** Shanghai Municipal Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-12-28
- **Final completion:** 2027-02-01
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07639866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07639866, "Combination of CXD and Restrictive Ketogenic Diet Against MASLD". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07639866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*